Stevens, R., Kothari, V., Adler, A. and Stratton, I. (2001) The UKPDS risk engine: A model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clinical Science, 101, 671-679. http://dx.doi.org/10.1042/CS20000335
 McEwan, P., Williams, J., Griffiths, J., Bagust, A., Peters, J., Hopkinson, P. and Currie, C.J. (2004) Evaluating the performance of the Framingham equations in a population with diabetes. Diabetic Medicine, 21, 318-323. http://dx.doi.org/10.1111/j.1464-5491.2004.01139.x
 Coleman, R., Stevens, R., Retnakaran, R. and Holman, R. (2007) Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in Type 2 diabetes. Diabetes Care, 30, 1292-1294. http://dx.doi.org/10.2337/dc06-1358
 Hernaez, R., Choque, L., Gimenez, M., Marquez, J. and Conget, I. (2004) Coronary risk assessment in subjects with Type 2 diabetes mellitus. General population-based scores or specific scores? Revista Espanola de Cardiología, 57, 577-580.
 Song, S. and Brown, P. (2004) Coronary heart disease risk assessment in diabetes mellitus: Comparison of UKPDS risk engine with Framingham risk assessment and its clinical implications. Diabetic Medicine, 21, 238-245. http://dx.doi.org/10.1111/j.1464-5491.2004.01116.x
 Protopsaltis, I. and Nikolopoulos, G. and Melidonis, A. (2004) Comparative study of the prognostic value for coronary heart disease risk between the UK prospective diabetes study and Framingham models. Diabetes Care, 27, 277-278. http://dx.doi.org/10.2337/diacare.27.1.277
 Stephens, J., Ambler, G., Vallance, P., Betteridge, D., Humphries, S. and Hurel, S. (2004) Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? The European Journal of Cardiovascular Prevention & Rehabilitation, 11, 521-528.
 Guzder, R., Gatling, W., Mullee, M., Mehta, R. and Byrne, C. (2005) Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: Results from a United Kingdom study. Diabetic Medicine, 22, 554-562. http://dx.doi.org/10.1111/j.1464-5491.2005.01494.x
 Game, F., Bartlett, W., Bayley, G. and Jones, A. (2001) Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus. Diabetes, Obesity and Metabolism, 3, 279-286. http://dx.doi.org/10.1046/j.1463-1326.2001.00131.x
 Metcalf, P., Wells, S., Scragg, R. and Jackson, R. (2008) Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus. NZ Medical Journal, 121, 49-57.
 National Collaborating Centre for Primary Care (NCCPC) (2008) Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. Clinical guideline 67. London, NICE.
 Joint British Societies (JBS). (2005) JBS 2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. Heart, 91, V1-V5. http://dx.doi.org/10.1136/hrt.2005. 079988
 Expert panel on detection e, and treatment of high blood cholesterol. (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. The Journal of the American Medical Association, 285, 2486-2497.
 Alberti, K. and Zimmet, P. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553. http://dx.doi.org/10.1002/(SICI)1096-9136(199807) 15:7<539::AID-DIA668>3.0.CO;2-S
 Abbot, R., Donahue, R., Kannel, W. and Wilson, P. (1988) The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. The Journal of the American Medical Association, 260, 3456-3460. http://dx.doi.org/10.1001/jama.1988.03410230074031
 Wilson, S., Johnston, A., Robson, J., Poulter, N., Collier, D., Feder, G. and Caulfield, M.J. (2003) Predicting coronary risk in the general population—Is it necessary to measure high-density lipoprotein cholesterol? Journal of Cardiovascular Risk, 10, 137-141. http://dx.doi.org/10.1097/ 00043798-200304000-00009